![Azmi Nabulsi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Azmi Nabulsi
Chief Executive Officer at
Vaderis Therapeutics AG
Net worth: 10 M $ as of 2026-08-30
Profile
Dr. Azmi Nabulsi, MD, is a President & Chief Executive Officer at Vaderis Therapeutics AG.
Dr. Nabulsi was previously employed as a Chief Operating Officer by Phathom Pharmaceuticals, Inc., a Chief Medical & Scientific Officer by Takeda Pharmaceutical Co., Ltd., and a Head-Immunology & Oncology Ventures by Abbott Laboratories.
He also served on the board at ReAlta Life Sciences, Inc. He received his graduate degree from the University of Minnesota and a doctorate degree from Ain Shams University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-22 | 1,016,228 ( 1.26% ) | 10 M $ | 2026-08-30 |
Azmi Nabulsi active positions
| Companies | Position | Start |
|---|---|---|
Vaderis Therapeutics AG
 Vaderis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops targeted therapies for rare diseases associated with vascular malformations | Chief Executive Officer | 2025-07-31 |
Former positions of Azmi Nabulsi
| Companies | Position | End |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Founder | 2025-06-02 |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Director/Board Member | 2022-12-31 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | 2018-09-30 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2003-12-31 |
Training of Azmi Nabulsi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ain Shams University
 Ain Shams University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
Vaderis Therapeutics AG
Vaderis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops targeted therapies for rare diseases associated with vascular malformations | Health Technology |
- Stock Market
- Insiders
- Azmi Nabulsi
